Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Pfizer in court over Chinese stealing trade secrets

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Feb 08, 2023 12:27pm

167 Views

Post# 35274747

RE:RE:RE:Pfizer in court over Chinese stealing trade secrets

In a separate trade secrets dispute, Pfizer filed suit against former employee Chun Xiao Li in 2021, accusing the staffer of uploading more than 12,000 files, including “confidential Pfizer documents,” to a personal Google Drive account, as well as personal devices.

https://www.fiercepharma.com/pharma/pfizer-says-former-employee-stole-trade-secrets-megablockbuster-covid-19-vaccine

<< Previous

Bullboard Posts

Next >>

Rick Rule’s election insights: Gold, USD, and Canadian gas